Lombardi Comprehensive Cancer Center, Georgetown

Washington D.C., District of Columbia

0 studies enrolling now · 1 studies all time

What they study most

Solid Tumors

Studies at this site

• Study of RXDX-105, Potent RET Inhibitor in Patients With Advanced Lung Cancer and Other Solid Tumors — Completed